EPISODE · Mar 29, 2026 · 5 MIN
今天3分钟我们来聊聊同济双靶点CAR-T攻克TP53淋巴瘤
from 源于细胞BioInsid的个人播客
同济医院创新双靶点CAR-T疗法，让TP53突变淋巴瘤患者5年生存率达70%，改写“最难治”历史，为全球数万患者带来新生希望。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊同济双靶点CAR-T攻克TP53淋巴瘤
0:00
5:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 5 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on March 29, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!